Stacey Denenberg Seltzer serves as Executive at Aimmune Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Stacey Denenberg Seltzer has executed 6 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Oct 13, 2020 involved selling 7,840 shares valued at $270.5K.
Stacey Denenberg Seltzer currently holds 18,061 shares of Aimmune Therapeutics, Inc. (AIMT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stacey Denenberg Seltzer has been a net neutral trader of AIMT stock. They have purchased $0 and sold $0 worth of shares.
Stacey Denenberg Seltzer's most recent insider trade was on Oct 13, 2020, when they sold 7,840 shares at $34.50 per share.
Get notified when new Form 4 filings are submitted
| 10,221 |
| $34.50 |
| Discretionary |
| May 27, 2020 | AIMT | $0 | Award | 7,840 | $N/A | Discretionary |
| May 23, 2019 | AIMT | $0 | Award | 6,442 | $N/A | Discretionary |
| May 23, 2018 | AIMT | $0 | Award | 3,750 | $N/A | Discretionary |
| Dec 6, 2017 | AIMT | $0 | Other | 29 | $N/A | Discretionary |